1. Sandovici, Ionel, Fernandez-Twinn, Denise S, Campbell, Niamh, Ozanne, Susan E, Constância, Miguel. 2024. Overexpression of Igf2-derived Mir483 inhibits Igf1 expression and leads to developmental growth restriction and metabolic dysfunction in mice. In Cell reports, 43, 114750. doi:10.1016/j.celrep.2024.114750. https://pubmed.ncbi.nlm.nih.gov/39283743/
2. Li, Xingnan, Nadauld, Lincoln, Ootani, Akifumi, Ji, Hanlee P, Kuo, Calvin J. 2014. Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture. In Nature medicine, 20, 769-77. doi:10.1038/nm.3585. https://pubmed.ncbi.nlm.nih.gov/24859528/
3. Naboulsi, Rakan, Larsson, Mårten, Andersson, Leif, Younis, Shady. 2021. ZBED6 regulates Igf2 expression partially through its regulation of miR483 expression. In Scientific reports, 11, 19484. doi:10.1038/s41598-021-98777-0. https://pubmed.ncbi.nlm.nih.gov/34593874/
4. Zhang, Yiqun, Hu, Ji-Fan, Wang, Hong, Hoffman, Andrew R, Li, Wei. . CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors. In Oncotarget, 8, 34177-34190. doi:10.18632/oncotarget.10918. https://pubmed.ncbi.nlm.nih.gov/27486969/
5. Shang, Fenqing, Guo, Xuan, Chen, Yueer, Lai, Baochang, Bai, Liang. 2022. Endothelial MicroRNA-483-3p Is Hypertension-Protective. In Oxidative medicine and cellular longevity, 2022, 3698219. doi:10.1155/2022/3698219. https://pubmed.ncbi.nlm.nih.gov/35222797/
6. Zhang, Jin, He, Yangyang, Yan, Xiaosong, Jing, Zhi-Cheng, Shyy, John Y-J. 2020. MicroRNA-483 amelioration of experimental pulmonary hypertension. In EMBO molecular medicine, 12, e11303. doi:10.15252/emmm.201911303. https://pubmed.ncbi.nlm.nih.gov/32324970/
7. Qiu, Shuang, Qiu, Yingjia, Li, Yong, Cheng, Yi, Liu, Yawen. 2023. Nexus between genome-wide copy number variations and autism spectrum disorder in Northeast Han Chinese population. In BMC psychiatry, 23, 96. doi:10.1186/s12888-023-04565-7. https://pubmed.ncbi.nlm.nih.gov/36750796/
智鼠故事 
